DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones

被引：50
|
作者：
Bébéar, CM [1 ]
Renaudin, H [1 ]
Charron, A [1 ]
Clerc, M [1 ]
Pereyre, S [1 ]
Bébéar, C [1 ]
机构：
[1] Univ Bordeaux 2, Bacteriol Lab, F-33076 Bordeaux, France
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 10期
关键词：
D O I：
10.1128/AAC.47.10.3323-3325.2003
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Twelve clinical isolates of Ureaplasma spp. and one isolate of Mycoplasma hominis were examined for resistance to fluoroquinolones. Previously described mutations at positions 83 and 95 in GyrA (Escherichia coli numbering) and positions 80 and 87 in ParC were found. Unusual alterations were described at positions ParC 123 and 134.
引用
收藏
页码：3323 / 3325
页数：3
相关论文
共 50 条
  • [1] Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones
    Piccinelli, Giorgio
    Gargiulo, Franco
    Biscaro, Valeria
    Caccuri, Francesca
    Caruso, Arnaldo
    De Francesco, Maria Antonia
    INFECTION GENETICS AND EVOLUTION, 2017, 47 : 64 - 67
  • [2] Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants
    Ehrmann, Elodie
    Jolivet-Gougeon, Anne
    Bonnaure-Mallet, Martine
    Fosse, Thierry
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (08) : 2208 - 2212
  • [3] Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro
    Bébéar, CM
    Renaudin, H
    Charron, A
    Bové, JM
    Bébéar, C
    Renaudin, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2304 - 2311
  • [4] Role of Mutations in DNA Gyrase and Topoisomerase IV in Fluoroquinolones-Resistance of Mycoplasma gallisepticum Obtained in vitro and in vivo
    Li, Jian
    Lu, Dian-Hong
    Liu, Zhi-Jie
    Zhang, Xiao-Hua
    Wei, Fei-Long
    Liu, Ya-Hong
    Jiang, Hong-Xia
    JOURNAL OF ANIMAL AND VETERINARY ADVANCES, 2012, 11 (13): : 2327 - 2332
  • [5] Tetracycline and fluoroquinolone resistance in clinical Ureaplasma spp. and Mycoplasma hominis isolates in France between 2010 and 2015
    Meygret, A.
    Le Roy, C.
    Renaudin, H.
    Bebear, C.
    Pereyre, S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (10) : 2696 - 2703
  • [6] Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones
    Pestova, E
    Beyer, R
    Cianciotto, NP
    Noskin, GA
    Peterson, LR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) : 2000 - 2004
  • [7] Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates
    Bansal, Sandhya
    Tandon, Vibha
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (03) : 253 - 255
  • [8] Sparfloxacin selects gyrase mutations in first-step Mycoplasma hominis mutants, whereas ofloxacin selects topoisomerase IV mutations
    Kenny, GE
    Young, PA
    Cartwright, FD
    Sjöström, KE
    Huang, WM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) : 2493 - 2496
  • [9] Molecular mechanism of fluoroquinolones resistance in Mycoplasma hominis clinical isolates
    Meng, Dong-Ya
    Sun, Chang-Jian
    Yu, Jing-Bo
    Ma, Jun
    Xue, Wen-Cheng
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2014, 45 (01) : 239 - 242
  • [10] Antimicrobial Resistance in Clinical Ureaplasma spp. and Mycoplasma hominis and Structural Mechanisms Underlying Quinolone Resistance
    Yang, Ting
    Pan, Lianlian
    Wu, Ningning
    Wang, Lin
    Liu, Zhen
    Kong, Yingying
    Ruan, Zhi
    Xie, Xinyou
    Zhang, Jun
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (06)
12345